Patients With Brain Metastases From HER2-positive Breast Cancer

Update Il y a 4 ans
Reference: NCT02135159

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine the optimal sequences of combined trastuzumab emtansine (T-DM1) and whole-brain radiotherapy in patients presenting brain metastases from HER2-positive breast cancer in terms of acute toxicities and blood/cerebrospinal fluid T-DM1 pharmacokinetics.


Inclusion criteria

  • HER2-positive breast cancer

Links